1. Home
  2. BRTX vs AIDX Comparison

BRTX vs AIDX Comparison

Compare BRTX & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

SELL

Current Price

$1.52

Market Cap

3.1M

Sector

Health Care

ML Signal

SELL

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

HOLD

Current Price

$0.20

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRTX
AIDX
Founded
1997
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.9M
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
BRTX
AIDX
Price
$1.52
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.6K
★ 208.0K
Earning Date
11-24-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.48
EPS
★ N/A
N/A
Revenue
$81,000.00
★ $2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
$383.87
$95.73
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.14
$0.18
52 Week High
$28.99
$18.96

Technical Indicators

Market Signals
Indicator
BRTX
AIDX
Relative Strength Index (RSI) 41.96 28.39
Support Level $1.32 N/A
Resistance Level $2.93 $0.27
Average True Range (ATR) 0.14 0.03
MACD 0.05 0.00
Stochastic Oscillator 53.07 16.65

Price Performance

Historical Comparison
BRTX
AIDX

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: